logo

FDA Calendar

Share
Company Name Merck & Co Inc.
Drug Name Vericiguat(NDA)
Event Name FDA decision on Vericiguat in Patients with symptomatic chronic Heart Failure and Reduced Ejection Fraction
Event Date 01/20/2021
Outcome Date
Outcome
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar